| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 08/27/2009 | WO2009105712A1 Heterocyclic compounds and compositions as c-kit and pdgfr kinase inhibitors |
| 08/27/2009 | WO2009105355A2 A novel neospora caninum vaccine |
| 08/27/2009 | WO2009104988A1 Pharmacological adjuvants based on coordination compounds of d-metals |
| 08/27/2009 | WO2009104388A1 Prophylactic/therapeutic agent for collagenosis |
| 08/27/2009 | WO2009103727A2 Combination of an iron chelator and an immunosuppressant and use thereof |
| 08/27/2009 | WO2009103319A2 Proteins ezrin, serpin b5, peroxiredoxin-2 and heat shock protein beta-1 as autoantigens for psoriasis vulgaris and poststreptococcal diseases |
| 08/27/2009 | WO2009103312A1 Ezrin, serpin b5, peroxiredoxin-2 and heat shock protein beta-1 as autoantigens for psoriasis and poststreptococcal diseases |
| 08/27/2009 | WO2009103199A1 A g-csf conjugate modified by water-soluble polymer |
| 08/27/2009 | WO2009103157A1 Mfap4 as a marker for regulatory cells and anti-cancer cells |
| 08/27/2009 | WO2009086439A3 2-methylene-(20s,25s)-19,26-dinor-vitamin d analogs |
| 08/27/2009 | WO2009086438A3 2-methylene-(20s,25r)-19,26-dinor-vitamin d analogs |
| 08/27/2009 | WO2009083738A3 Rna delivery vehicles |
| 08/27/2009 | WO2009076778A8 Recombinant influenza virus-like particles (vlps) produced in transgenic plants expressing hemagglutinin |
| 08/27/2009 | WO2009063215A3 Use of crth2 antagonist compounds |
| 08/27/2009 | WO2009063202A3 Use of crth2 antagonist compounds |
| 08/27/2009 | WO2009033811A3 Therapeutic uses of muroctasin and kisspeptin13 and compositions thereof |
| 08/27/2009 | WO2009033760A3 Use of fibronectin fragment (196-203 ) as a therapeutic agent |
| 08/27/2009 | WO2009033668A3 Use of a peptide as a therapeutic agent |
| 08/27/2009 | WO2009033667A3 Use of a peptide as a therapeutic agent |
| 08/27/2009 | WO2008142513A3 Phosphate-modified oligonucleotide analogs with immunostimulatory activity |
| 08/27/2009 | WO2008095093A3 Method of increasing cellular function and health of glutathione deficient animals |
| 08/27/2009 | US20090217392 Anti- integrin antibodies, compositions, methods and uses |
| 08/27/2009 | US20090215995 isolated nucleic acids encoding B7-related polypeptides, including BSL3, which modulate cells that are important for immune and inflammatory responses, such as T-cells |
| 08/27/2009 | US20090215900 Composition and method for providing glutamine |
| 08/27/2009 | US20090215897 Method for treatment and prevention of respiratory insufficiency |
| 08/27/2009 | US20090215890 Gamma-hydroxybutyrate compositions containing carbohydrate, lipid or amino acid carriers |
| 08/27/2009 | US20090215861 Antisense oligonucleotides for treating allergy and neoplastic cell proliferation |
| 08/27/2009 | US20090215851 Method of Preparing a Porphyrin Derivative, a Porphyrin Derivative, Use of Said Porphyrin derivative and a pharmaceutical composition containing said porphyrin derivative |
| 08/27/2009 | US20090215819 Anti-infective and immunomodulatory compounds |
| 08/27/2009 | US20090215813 Histone deacetylase inhibitors as immunosuppressants |
| 08/27/2009 | US20090215809 crystalline calcium (3S)-{[(1R)-isobutanoyloxyethoxy]carbonylaminomethyl}-5-methyl-hexanoate hydrate; sustained release oral dosage formualtion with opioid agonist, selective serotonin re-uptake inhibitor and noradrenaline re-uptake inhibitor; an inflammatory disease, neuropathic pain, anxiety, psychosis |
| 08/27/2009 | US20090215771 Jun N-terminal kinase inhibitors; 1H-pyrrolo[2,3-b]pyridines 3-substituted with a C 5-7 carbocycle and 5-substituted by a 5-member heterocycle; 3-(p-(dimethylamino)phenyl)-5-(2-thiazolyl-1H-pyrrolo[2,3-b]pyridine; neurodegenerative disorders related to apoptosis and/or inflammation |
| 08/27/2009 | US20090215766 Tetracyclic inhibitors of janus kinases |
| 08/27/2009 | US20090215736 inhibitors of apoptosis and IL-1 beta secretion; mediate cell apoptosis and inflammation; good cell penetration and pharmacokinetic properties; [3S/R(2S)]3-[2-(Carbazol-9-yl-2-oxo-ethyl)-pentanoylamino]-5-fluoro-4-oxo-pentanoic acid |
| 08/27/2009 | US20090215724 Pyrrolopyrazine kinase inhibitors |
| 08/27/2009 | US20090215722 Dextran; inhibit rejection of transplanted cells by the immune system of the recipient; gene therapy; saturating the antigen presenting cells (APC's) with nonimmunogenic agents; readily phagocytosed by APCs |
| 08/27/2009 | US20090215707 Compound having cyclic structure and use thereof |
| 08/27/2009 | US20090215672 Cys-Rich, Cell Surface Glycoproteins |
| 08/27/2009 | US20090214666 Chitin microparticles and their medical uses |
| 08/27/2009 | US20090214598 Monovalent and polyvalent synthetic polysaccharide antigens for immunological intervention in disease |
| 08/27/2009 | US20090214597 Non-injection immunotherapy |
| 08/27/2009 | US20090214593 Immunogen platform |
| 08/27/2009 | US20090214591 Immunogens for Vaccines Against Antigenically Variable Pathogens and Diseases |
| 08/27/2009 | US20090214578 Immunostimulatory Single-Stranded Ribonucleic Acid with Phosphodiester Backbone |
| 08/27/2009 | US20090214573 Modulation of bne development |
| 08/27/2009 | US20090214570 Methods and compositions for immunizing against chlamydia infection |
| 08/27/2009 | US20090214558 NOVEL MAdCAM ANTIBODIES |
| 08/27/2009 | US20090214551 High Affinity Hiv T Cell Receptors |
| 08/27/2009 | US20090214549 Antigenic Epitopes Of Inteleukin-21, Related Antibodies And Their Use In Medical Field |
| 08/27/2009 | US20090214537 Serum Resistance Factors of Gram Positive Bacteria |
| 08/27/2009 | US20090214529 Kinesin inhibitors |
| 08/27/2009 | US20090214526 For use as antibody biodrug with improved therapeutic, production properties |
| 08/27/2009 | DE102008000351A1 Preparing ebastine containing granules, useful to treat e.g. allergic rhinitis, comprises preparing granules from a solution of ebastine in cyclic ether solvent and a powder of one or more existing solid carrier materials, and drying |
| 08/27/2009 | CA2715822A1 Combination of an iron chelator and an immunosuppressant and use thereof |
| 08/27/2009 | CA2714700A1 Heterocyclic compounds and compositions as c-kit and pdgfr kinase inhibitors |
| 08/26/2009 | EP2093293A2 G-Protein coupled receptors |
| 08/26/2009 | EP2093228A1 Pyrroline-2-one derivatives against cell releasing tumor necrosis factor, preparation methods and uses thereof |
| 08/26/2009 | EP2093214A1 Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents |
| 08/26/2009 | EP2092937A2 Immunotherapeutic and immunoprophylactic reagents |
| 08/26/2009 | EP2092935A1 Pharmaceutical compositions for the treatment of asthma |
| 08/26/2009 | EP2092058A1 Cancerous disease modifying antibodies |
| 08/26/2009 | EP2091967A1 Crystalline composition of gm-csf/gm-csfr |
| 08/26/2009 | EP2091950A1 Oxadiazole derivatives as s1p1 receptor agonists |
| 08/26/2009 | EP2091949A1 Indole derivatives as s1p1 receptor agonists |
| 08/26/2009 | EP2091568A2 Fusion proteins comprising a anti-inflammatory cytokine and an antigen for treatment of immune disorders |
| 08/26/2009 | EP2091544A2 Composition for the prevention and/or treatment of diseases associated with tnf and/or il-12 overexpression |
| 08/26/2009 | EP2091535A1 Use of pkc inhibitors in transplantation |
| 08/26/2009 | EP1561759B9 Cell death-inducing agent |
| 08/26/2009 | EP1450855B1 Suppression of allergic reactions by transdermal administration of allergens in conjunction with or conjugated to toxin subunits or fragments thereof |
| 08/26/2009 | EP1389096B9 Delivery of opioids through an inhalation route |
| 08/26/2009 | EP1368057B1 Method to enhance the immunogenicity of an antigen |
| 08/26/2009 | EP1218375B1 Pharmaceutically active sulfonyl amino acid derivatives |
| 08/26/2009 | EP1207879B1 Nicotine receptor agonists in stem cell and progenitor cell recruitment |
| 08/26/2009 | EP1147212B1 T helper cell epitopes |
| 08/26/2009 | EP1061812B1 Food products having enhanced cocoa polyphenol content and processes for producing same |
| 08/26/2009 | EP1012187B1 Chemokine peptides, variants, derivatives and analogs. their use in methods to inhibit or augment an inflammatory response |
| 08/26/2009 | CN101517082A CpG oligonucleotide analogs containing hydrophobic T analogs with enhanced immunostimulatory activity |
| 08/26/2009 | CN101516914A Antibodies against CCR5 and uses thereof |
| 08/26/2009 | CN101516874A Pyrrole derivatives useful for the treatment of cytokine-mediated diseases |
| 08/26/2009 | CN101516869A Heterocyclic substituted piperazine compounds with CXCR3 antagonist activity |
| 08/26/2009 | CN101516839A Compounds which modulate the cb2 receptor |
| 08/26/2009 | CN101516398A Antagonists of protease activated receptor-1 (PAR1) |
| 08/26/2009 | CN101516345A Pharmaceutical compositions comprising an S1P modulator |
| 08/26/2009 | CN101514333A Immunologic tolerance dendritic cell, preparation method thereof and special culture medium |
| 08/26/2009 | CN101513445A Sea horse health maintaining liquid and preparation method thereof |
| 08/26/2009 | CN101513440A Sonchus plant extract and application thereof in preparing medicament for curing skin diseases |
| 08/26/2009 | CN100532563C Pharmaceutical product comprising tissue of the male vegetal reproductive system |
| 08/26/2009 | CN100532374C Novel tricyclic compounds useful for the treatment of inflammatory and allergic disorders, process for their preparation and pharmaceutical compositions containing same |
| 08/26/2009 | CN100531802C Pseudo-type retrovirus vector containing membrane protein having hemagglutinin activity |
| 08/26/2009 | CN100531741C Magnesium isoglycyrrhetate oral preparation and its making method |
| 08/25/2009 | US7579439 Modulation of IL-2- and IL-15-mediated T cell responses |
| 08/25/2009 | US7579435 Somatostatin-dopamine chimeric analogs |
| 08/25/2009 | US7579432 Cyclic peptides as G-protein-coupled receptor antagonists |
| 08/25/2009 | US7579357 Antidiabetic agents; obesity; controlling appetite |
| 08/25/2009 | US7579348 selective antagonists of A2B adenosine receptors; for improving insulin sensitivity; asthma |
| 08/25/2009 | US7579347 Vanilloid receptor ligands and their use in treatments |
| 08/25/2009 | US7579342 Pteridine compounds for the treatment of psoriasis |
| 08/25/2009 | US7579170 Method for preparing monoclonal antibodies capable of activating effector cells expressing FCγRIII |
| 08/25/2009 | US7579023 Method of preparation and composition of a water soluble extract of the bioactive component of the plant species Uncaria for enhancing immune, anti-inflammatory, anti-tumor and DNA repair processes of warm blooded animals |
| 08/25/2009 | US7579006 Method of treating immune pathologies with low dose estrogen |